Successfully treating type 2 diabetes may involve focusing on brain neurons, rather than simply concentrating on obesity or insulin resistance, according to a study published today in the Journal of Clinical Investigation.

Researchers from the University of Tokyo have found a way to observe clotting activity in blood as it happens—without needing invasive procedures. Using a new type of microscope and artificial intelligence (AI), their study shows how platelet clumping can be tracked in patients with coronary artery disease (CAD), opening the door to safer, more personalized treatment.

A new, incision-free technique developed at UVA Health to treat debilitating brain lesions called cerebral cavernous malformations, or cavernomas, has shown great promise in early testing, halting the growth of the lesions almost entirely.

Elucent Medical announced today that it received FDA breakthrough device designation for its EnVisio X1 In-Body Spatial Intelligence system.

MIT engineers designed polymer microparticles that can deliver vaccines at predetermined times after injection.

First-of-its-kind platform offers real-time fetal heart documentation and congenital heart disease detection, revolutionizing prenatal care and diagnosis.

GE HealthCare (Nasdaq: GEHC) today announced the launch of its CleaRecon DL technology for enhancing CBCT imaging.

EndoQuest Robotics announced today that investigators completed the first procedures of the PARADIGM pivotal clinical trial of its surgical robot